FcRn plays a central role in regulating the half-life of IgG antibodies and albumin, making it a critical target in both antibody engineering and autoimmune disease therapy. This article explores the biology of FcRn, the use of HMEC-1 cells for measuring FcRn-mediated IgG recycling, and the assays used to support the development of next-generation biologics and FcRn-targeted therapeutics.
1/ What is the biological function of FcRn?
Neonatal Fc receptor for IgG (FcRn) is a heterodimeric protein similar in structure to MHC class I that binds to the Fc region of immunoglobulin G (IgG). It consists of the FcRn heavy chain (encoded by FCGRT) associated with β2-microglobulin (B2M) and is expressed in over 25 tissue types, with high expression levels observed in the spleen and intestine.
FcRn contributes to effective humoral immunity by protecting IgG antibodies from degradation, recycling them and extending their half-life in circulation. It also regulates the homeostasis of serum albumin.
FcRn plays a vital role in regulating the level of albumin and IgG antibodies in circulation by binding albumin and the Fc region of an IgG at low pH (about pH 6.0) in endosomes. It then diverts them from lysosomal degradation and recycles them for release into the neutral pH (pH 7.0 to 7.4) of the extracellular compartment.
2/ How is FcRn function exploited for antibody engineering?
The IgG antibody stabilisation function of FcRn can be exploited when engineering therapeutic antibodies: mutations introduced into the Fc fragment can increase binding to FcRn, which improves their half-life and therefore their therapeutic efficacy.
Measuring FcRn-dependent IgG antibody recycling is therefore a key step in developing and characterising novel therapeutic antibodies, Fc-engineered biologics and biosimilars. Researchers often use HMEC-1 cells for this purpose.
3/ Why are HMEC-1 cells used to perform IgG antibody recycling assays?
The HMEC-1 cell line (human microvascular endothelial cells, immortalised) is one of the most widely used in vitro models for evaluating the internalisation and recycling of therapeutic IgG antibodies. As an endothelial cell system, it is highly physiologically relevant because endothelial cells are considered one of the major sites of FcRn-mediated IgG recycling in vivo. HMEC-1 cells express the neonatal Fc receptor (FcRn), enabling the study of key processes involved in IgG trafficking, including cellular uptake, endosomal sorting and recycling back to the cell surface. This makes them well suited for assessing the recycling efficiency of therapeutic antibodies and engineered Fc variants.
Together, these characteristics make HMEC-1 cells a valuable platform for comparing antibody candidates, screening Fc-engineered variants and studying FcRn-mediated recycling mechanisms.
4/ How does the FcRn: IgG Recycling HMEC-1 Cell Pool work?
BPS Bioscience’s cell-based IgG antibody recycling assays are designed to evaluate FcRn-mediated antibody trafficking and recycling activity in physiologically relevant HMEC-1 cells. Sometimes termed HERA (human endothelial cell-based recycling assay), these assays support lead optimisation and functional characterisation workflows by providing quantitative data on IgG binding to FcRn and recycling behaviour.

The assays use HMEC-1 cells genetically engineered to express FcRn, for robust, stable expression of FCGRT and B2M. The cells were extensively validated by measuring the recycling of well-known IgG1 antibodies such as nivolumab, rituximab, trastuzumab, basiliximab and alirocumab.


5/ When is it desirable to block IgG binding to FcRn?
FcRn itself is a therapeutic target for some autoimmune diseases since disrupting the FcRn/IgG interaction is expected to increase IgG antibody clearance, including clearance of autoantibodies, thereby decreasing their concentration in patients. The first FDA-approved drug targeting FcRn (efgartigimod) is an Fc fragment decoy that provided proof-of-concept and is now used to treat the autoimmune disease myasthenia gravis.


News – Curated by Amanda Scott, Alias Group Creative
Follow her on Bluesky
New OpenAI benchmark tests how well models reason complex drug discovery tasks
MedChemBench tests AI reasoning across 99 chemistry problems, exposing gaps in drug property prediction. Key Takeaways MedChemBench evaluates model performance across 99 medicinal chemistry problems drawn from 117 papers and patents. GPT-6 Astra earned [...]
New CRISPR therapy is poised to gain first FDA approval to alter genes inside the body
A single infusion that edits a gene directly inside a patient's liver appears to keep working four years later, according to its developer, Intellia Therapeutics. The treatment now awaits a decision from the US [...]
Blockchain in Healthcare: Real Applications
Blockchain in healthcare refers to the use of distributed ledger technology to secure, manage, and share medical data and processes. Applications include patient record management, prescription tracking, and supply chain authentication, all designed to [...]
Our books are available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
Scientists Discover a Surprising New Power of Honey That Could Protect Your Skin
Honey’s medical uses may go beyond healing wounds, as laboratory experiments suggest multifloral honey could strengthen human skin cells’ defenses against damaging UV radiation. Ultraviolet (UV) radiation from sunlight can accelerate skin aging and [...]
Scientists Discover That Male and Female Hearts Age in Surprisingly Different Ways
A new study reveals surprising differences in how male and female hearts age at the cellular level. The heart may age very differently from one region to another. A detailed study of mouse hearts [...]
An Ancient Virus May Hold the Secret to What Makes the Human Brain Different
Could a virus that infected chimpanzees millions of years ago help explain how the human brain became different? Researchers at Lund University have discovered that ancient viral DNA embedded in the chimpanzee genome silences [...]
Could a Nasal Spray Stop Alzheimer’s Before Memory Loss Begins?
Protecting memory from Alzheimer’s may one day involve a nasal spray, with encouraging results in animals and evidence that its particles also protect human neurons grown in the lab. Alzheimer’s disease damages the connections [...]
A sceptical guide to AI agents in drug discovery
In conversation with Dr Eric Ma, Senior Principal Data Scientist at Moderna, Dr Raminderpal Singh examines what AI agents are actually good for, where the lock-in hides and why expertise has become more valuable [...]
Study identifies new targets for antiviral drugs against coronaviruses
A study led by researchers at the University of California San Diego School of Medicine and University of California, Riverside (UCR) School of Medicine has identified new targets for antiviral drugs against coronaviruses, including [...]
“Nearly Everybody Had Given Up” – Scientists Finally Solve a 60-Year Chemistry Mystery
After more than six decades of failed attempts, chemists have achieved a breakthrough involving a class of molecules long considered too unstable to isolate. Chemists have succeeded in isolating a group of molecules that [...]
Depression Symptoms Improved in Just 48 Hours After a Single Psychedelic Dose
A single dose of psilocybin produced rapid antidepressant effects in a small Swedish clinical trial, with improvements lasting for weeks. A single dose of psilocybin, the psychedelic compound found in magic mushrooms, produced rapid [...]
GHCE Concept
From the preface of the book Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artificial Intelligence, Edited by Frank Boehm: Since the publication of my first book (Nanomedical Device and Systems [...]
Human Bodies Are Producing Two Billion Tons of CO2 a Year
A new study reveals that the amount of carbon dioxide produced by human metabolism has increased dramatically over three decades. The carbon dioxide produced by human bodies as they convert food into energy increased [...]
A Hidden DNA Mechanism Could Explain How 20% of Human Cancers Develop
Researchers have identified an unexpected molecular vulnerability in cancers carrying BAF mutations. Mutations found in roughly 20% of human cancers may promote tumor growth by changing how DNA is organized inside cells. Researchers have [...]
Ebola kills over 5,300 in fastest-growing outbreak on record
Africa’s latest Ebola outbreak has killed nearly 5,400 people, the vast majority of them in the Democratic Republic of Congo (DRC), according to the continent’s top health agency. Africa Centres for Disease Control and [...]
















